Neurorecovery Effect of Novel Modified Erythropoietin on Ischemic Brain Injury

新型改良促红细胞生成素对缺血性脑损伤的神经恢复作用

• 批准号: 7751433
• 负责人: GUODONG CAO
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7751433
• 关键词: Acute; Adult; Adverse effects; Alteplase; Amino Acids; Attenuated; Binding; Blood; Blood Platelets; Cause of Death; Cell Culture Techniques; Cell Death; Cerebral Ischemia; Clinic; Clinical Trials; Coagulation Process; Data; Dose; Erythrocytes; Erythropoietin; Generations; Hematocrit procedure; Hormones; Hour; In Vitro; Infarction; Injection of therapeutic agent; Injury; Ischemia; Ischemic Brain Injury; Ischemic Stroke; Kidney; MAP Kinase Gene; MAPK3 gene; Mediating; Middle Cerebral Artery Occlusion; Modeling; Mus; Mutation; Neurologic; Neurological outcome; Neurons; Pathway interactions; Patients; Pharmaceutical Preparations; Production; Reagent; Recovery of Function; Regimen; Research; Risk Factors; Signal Pathway; Stroke; Testing; Therapeutic; abstracting; acute stroke; angiogenesis; brain repair; brain tissue; clinical application; clinically relevant; disability; high risk; improved; in vitro Model; in vivo; in vivo Model; mutant; neurogenesis; neurological recovery; neuroprotection; novel; patient population; post stroke; white matter injury